MINGXING TENG to Fusion Proteins, bcr-abl
This is a "connection" page, showing publications MINGXING TENG has written about Fusion Proteins, bcr-abl.
Connection Strength
0.737
-
The Dawn of Allosteric BCR-ABL1 Drugs: From a Phenotypic Screening Hit to an Approved Drug. J Med Chem. 2022 06 09; 65(11):7581-7594.
Score: 0.737